...The Pharma Innovation Journal 2014; 3(7): 08-12 ISSN: 2277- 7695 TPI 2014; 3(7): 08-12 © 2013 TPI www.thepharmajournal.com Received: 14-08-2014 Accepted: 28-08-2014 Rizwan Raheem Ahmed Professor, Department of Business Administration & Commerce Indus University, Pakistan Pharmaceutical marketing mix strategy and physician’s prescription behavior Rizwan Raheem Ahmed ABSTRACT Purpose: This research paper gives an insight about the processes used by local and MNCs pharmaceutical companies in Pakistan.The purpose of our research is to examine that what factors affect physician prescription behavior based on ethical grounds. Methodology: This research focuses on the strategies and marketing tools used by pharmaceutical companies in Pakistan, and how Physicians behave against all these marketing strategies in terms of Prescription patterns. The questionnaire survey method is used for data collection and SPSS is used for Correlation and Regression techniques for the understanding of Physician’s prescription behaviour. Findings: The data analysis figuring out the correlation of these variables with the subject of the study i.e. factors influencing the prescribing behavior of the physician. The data shows the significance level of individual independent variable as Promotional tools. According to the results of Multiple Regressions Analysis (MRA) the researchers can conclude that independent variables have significant relationship with dependent variable. Therefore other all hypotheses...
Words: 3490 - Pages: 14
...September 2005 Project Portfolio Management at XYZ Pharma Early morning, Monday 29th August 2005. John Smith, head of portfolio management and strategic planning, was paging through the slides he had prepared for the Portfolio Management Board (PMB) meeting which would start at 9 am, and which was scheduled to last until Friday. “We have been preparing this meeting for weeks”, he thought, “and it seems the PMB has some tough decisions to make”. The PMB of XYZ Pharma, the pharmaceutical division of XYZ, one of the world’s leading companies in the life science sector, convenes yearly in August to review the composition of the research and development (R&D) project portfolio. It also meets on a monthly basis to monitor the project portfolio and make decisions regarding new developments. According to John Smith, “The PMB is an important decision making body because it shapes the future of the company by determining its product pipeline”. The PMB members include the CEO of XYZ, the CEO of XYZ Pharma, the heads of the different business units, the heads of Development, Research, Global Marketing and Strategic Planning, the regional heads for the US, Europe and Japan and the functional managers for Regulation, Clinical, Licensing, Technical Research and Development, and Patents. The portfolio group, led by John Smith, had analysed the project portfolio carefully and had highlighted several potential threats that required action. According to John, “There will be an indepth discussion...
Words: 5468 - Pages: 22
...September 2005 Project Portfolio Management at XYZ Pharma Early morning, Monday 29th August 2005. John Smith, head of portfolio management and strategic planning, was paging through the slides he had prepared for the Portfolio Management Board (PMB) meeting which would start at 9 am, and which was scheduled to last until Friday. “We have been preparing this meeting for weeks”, he thought, “and it seems the PMB has some tough decisions to make”. The PMB of XYZ Pharma, the pharmaceutical division of XYZ, one of the world’s leading companies in the life science sector, convenes yearly in August to review the composition of the research and development (R&D) project portfolio. It also meets on a monthly basis to monitor the project portfolio and make decisions regarding new developments. According to John Smith, “The PMB is an important decision making body because it shapes the future of the company by determining its product pipeline”. The PMB members include the CEO of XYZ, the CEO of XYZ Pharma, the heads of the different business units, the heads of Development, Research, Global Marketing and Strategic Planning, the regional heads for the US, Europe and Japan and the functional managers for Regulation, Clinical, Licensing, Technical Research and Development, and Patents. The portfolio group, led by John Smith, had analysed the project portfolio carefully and had highlighted several potential threats that required action. According to John, “There will be an indepth discussion...
Words: 5468 - Pages: 22
...September 2005 Project Portfolio Management at XYZ Pharma Early morning, Monday 29th August 2005. John Smith, head of portfolio management and strategic planning, was paging through the slides he had prepared for the Portfolio Management Board (PMB) meeting which would start at 9 am, and which was scheduled to last until Friday. “We have been preparing this meeting for weeks”, he thought, “and it seems the PMB has some tough decisions to make”. The PMB of XYZ Pharma, the pharmaceutical division of XYZ, one of the world’s leading companies in the life science sector, convenes yearly in August to review the composition of the research and development (R&D) project portfolio. It also meets on a monthly basis to monitor the project portfolio and make decisions regarding new developments. According to John Smith, “The PMB is an important decision making body because it shapes the future of the company by determining its product pipeline”. The PMB members include the CEO of XYZ, the CEO of XYZ Pharma, the heads of the different business units, the heads of Development, Research, Global Marketing and Strategic Planning, the regional heads for the US, Europe and Japan and the functional managers for Regulation, Clinical, Licensing, Technical Research and Development, and Patents. The portfolio group, led by John Smith, had analysed the project portfolio carefully and had highlighted several potential threats that required action. According to John, “There will be...
Words: 5468 - Pages: 22
...DOCUMENT TYPE DOC NO. REVISION Quality Management Policy TITLE ISSUED BY QMP-001 EFFECTIVE DATE 1.0 PAGE Q Pharma Quality System Manual rJ Boatman 16 Feb 2007 1 of 32 SUPERCEDES CSSC QSM-001 iPT QSM-001 QUALITY MANAGEMENT POLICY QUALITY SYSTEM MANUAL QMP-001 Rev. 1.0 Prepared by Date (Signed) Jeff Boatman, Director of Quality Reviewed by 01 Feb 2007 Date (Signed) Alexis Stroud, Compliance Manager Reviewed by 07 Feb 2007 Date (Signed) Raymond Roggero, iPT Business Unit Manager Reviewed by 2/7/07 Date (Signed) Robert Lorence, CSSC Business Unit Manager Approved by 9 Feb 2007 Date (Signed) Patrick Den Boer, President and CEO 16 Feb 2007 ©2007 Q Pharma Incorporated. Unauthorized reproduction or distribution prohibited. CONTROLLED DOCUMENT • VERIFY LATEST REVISION • PRINTED COPY IS UNCONTROLLED IF NOT STAMPED IN RED DOCUMENT TYPE DOC. NO. REVISION Quality Management Policy TITLE QMP-001 1.0 PAGE Quality System Manual TABLE OF CONTENTS 0. Page 2 of 32 1. 2. 3. 4. 5. 6. INTRODUCTION .........................................................................................................................4 0.1 General...............................................................................................................................4 0.2 Process Approach ................................................................................................................
Words: 10681 - Pages: 43
...Internship Report On Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ by Syeda Afrina Sarwar ID: 07304063 BRAC Business School BRAC University, Bangladesh August 2011 ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ Submitted By: Syeda Afrina Sarwar ID: 07304063 BRAC Business School Submitted To: ------------------------------------------------Ms. Rahnuma Ahmed Lecturer BRAC Business School BRAC University, Bangladesh August 2011 Letter of Transmittal August 10, 2011 Ms. Rahnuma Ahmed Lecturer BRAC BUSINESS SCHOOL BRAC University 66, Mohakhali Dhaka-1212 Subject: Submission of Internship Report Dear Madam, I am submitting an internship report titled for ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review of Costing Function’ as a part of the requirement of the course. Your guideline has been followed in every aspect of preparing this report. I have really enjoyed working on this project and I hope that my work would meet the level of your expectation. Any query on this report is appreciated. Thank You. Sincerely, Syeda Afrina Sarwar ID:07304063 Acknowledgement It’s difficult for me to thank all of those marvelous people who have contributed something of them to this report. There are of course some very special people who cannot go...
Words: 15094 - Pages: 61
...intelligence > Top ten global pharma Top ten global pharma Dr Vishal Agrawal, project manager, and Sunehli Jamwal, analyst, from GlobalData, highlight the top ten pharmaceutical companies by 2011 revenue. Pfizer 1 Johnson & Johnson 2 US pharmaceutical giant Pfizer maintained its top position in 2011 with stipulated revenue of $67.4 billion, up by 1% compared with $67.1 billion in 2010. The company’s new marketing strategy, coupled with focused organisational, financial and R&D restructuring efforts, compensated for the losses caused by Lipitor’s patent expiry. The approval of Xalkori for lung cancer, Inlyta and pneumococcal vaccine Prevnar 13 have proved to be a real lifeline for Pfizer. Moving ahead, the steady progress of the late-stage pipeline (with 22 projects in phase III and 11 under registration) will be a primary source of confidence for the company. The key strategy of the group is now to advance experimental drugs towards approval: these include Bosutinib, Tofacitinib, experimental clot-preventing drug Eliquis and its many pipeline drugs to make up for the inevitable decline in Lipitor revenue. With a view to reducing costs, Pfizer’s huge research budget has been cut by 12%. In 2012, Pfizer will focus on small to mid-sized deals and effective research partnerships to strengthen its portfolio in all therapeutic segments. Johnson & Johnson (J&J) reported 2011 revenues of $65 billion, a 5.6% increase over 2010. In 2011, the company generated 40% of its revenue...
Words: 1560 - Pages: 7
...EXPORT POTENTIAL AND STRATEGIES OF BEXIMCO PHARMACEUTICALS LTD. [pic] [pic] [pic] AN EXPLORATORY STUDY ON THE EXPORT POTENTIAL AND STRATEGIES OF BEXIMCO PHARMACEUTICALS LTD. Submitted To: Professor Golam Mohammed Chowdhury Chairman Internship and Placement Program Supervised By: Mr. Ridwanul Huq Lecturer Submitted by: Md. Shoeb-Bin-Mananan MBA 38th Day Roll-38D Institute of Business Administration University of Dhaka July 08, 2010 July 08, 2010 Professor Golam Mohammed Chowdhury The Chairperson Internship and Placement Committee Institute of Business Administration University of Dhaka Subject: Submission of Internship Report. Dear Sir, It is my pleasure to submit the internship report, which is done as a part of academic curriculum, to you for your kind evaluation. The report is prepared on “The Export Potential and Strategies of BEXIMCO Pharmaceuticals Ltd”. My organizational supervisor assigned me to prepare a report on the above mentioned subject and later my faculty advisor also approved it. I have put my best effort in preparing this report and to make it a worthy one. Each aspect of the problem is considered and studied as required. I shall try my best and shall be obliged to provide you with any kind of clarification concerning this report. Sincerely yours, ____________ Md. Shoeb-Bin-Mananan Roll No.: 38 Batch : 38th (Day) Major: Marketing MBA Program ...
Words: 10200 - Pages: 41
...Internship Report On Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ by Syeda Afrina Sarwar ID: 07304063 BRAC Business School BRAC University, Bangladesh August 2011 ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ Submitted By: Syeda Afrina Sarwar ID: 07304063 BRAC Business School Submitted To: ------------------------------------------------Ms. Rahnuma Ahmed Lecturer BRAC Business School BRAC University, Bangladesh August 2011 Letter of Transmittal August 10, 2011 Ms. Rahnuma Ahmed Lecturer BRAC BUSINESS SCHOOL BRAC University 66, Mohakhali Dhaka-1212 Subject: Submission of Internship Report Dear Madam, I am submitting an internship report titled for ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review of Costing Function’ as a part of the requirement of the course. Your guideline has been followed in every aspect of preparing this report. I have really enjoyed working on this project and I hope that my work would meet the level of your expectation. Any query on this report is appreciated. Thank You. Sincerely, Syeda Afrina Sarwar ID:07304063 Acknowledgement It’s difficult for me to thank all of those marvelous people who have contributed something of them to this report. There are of course some very special people who cannot go...
Words: 15094 - Pages: 61
...Considering the Apple iPad™ for Pharma Marketing Deciding whether to integrate a new technology into your marketing and communications efforts can be an exciting proposition filled with potential pitfalls and problems. This point of view aims to provide you with the best potential integration points for the Apple iPad within your pharma marketing efforts and some simple steps you can take to better evaluate its value of those efforts. The iPad is a tablet form factor computing device running an upgraded version of the iPhone OS, built by Apple Inc. Connectivity is via Wi-Fi or 3G data network through one of the following enabled communications channels: • Email • Safari Web browser • iTunes Store • iBook store eBook content • Apple and third-party developed apps • Games • Social media • Utilities While email and Web are proven channels that can be used to reach core audiences, the iPad does not offer a truly unique differentiating feature for pharma from these channels. Similar to music and video stores, the iPad will not initially offer any differentiators over the existing delivery channels on the PC, Mac and iPhone/iPod Touch platforms. However, mobile applications (apps) in general continue to be a steady marketing performer, and health apps are growing very quickly. Currently, there are over 150,000 apps in the Apple iTunes app store for the iPhone and iPod touch platforms. When iPad launches, nearly all of these will be available for download. In addition to these legacy...
Words: 1629 - Pages: 7
...Paper Report On Competitive Marketing Policies & Strategies Of Pharmaceutical Products in Bangladesh Submitted to Mr. Abdus Samad Chowdhury Senior Management Councilor Bangladesh Institute of Management Submitted By MD. MAHAFUZUR RAHMAN ID: 14MM028 Post Graduate Diploma In Marketing Management Date of Submission 21-12- 2014. Bangladesh Institute of Management Department of Marketing Management Letter of Transmittal December 21, 2014 Mr. Abdus Samad Chowdhury Bangladesh Institute of Management Subject: Request to accept my term paper report on competitive marketing policies & strategies of Pharmaceutical Products in Bangladesh. Dear Sir, I have given a topic on “Competitive Marketing Policies & Strategies of Pharmaceutical Products in Bangladesh” for writing a term paper for presentation, collection of primary data and secondary data. To do so, we sought the relevant information from books, newspaper and websites. We also went to many respondents who are closely related this entire process. I tried to collect all possible information and make this paper acceptable to all but there can be still existing mistake. So we like to request you to consider if any fault is found in this paper. Finally I would like to request you to accept our paper and permit us to present it before the panel of experts. Yours Sincerely Md. Mahafuzur Rahman Roll No : 14MM028 Post Graduate Diploma in Marketing Management. Bangladesh Institute...
Words: 9861 - Pages: 40
...Project Repositioning Strategy for Indian Pharmaceutical Companies in Global Context Submitted to PROFESSOR MURALI PATIBANDLA (FACULTY,CORPORATE STRATEGY AND POLICY) Submitted By Ravela Madhurika- 1211132 Tanveer Mohd Ansari-1211151 Contents Introduction .................................................................................................................................................. 3 Global Pharma Industry ............................................................................................................................ 3 Major players of the world pharmaceutical industry ................................................................................... 5 Major Players ............................................................................................................................................ 6 Pfizer Inc................................................................................................................................................ 6 GlaxoSmithKline .................................................................................................................................... 6 Sanofi-Aventis ....................................................................................................................................... 6 Novartis ................................................................................................................................................. 6 Indian Pharma Industry..........
Words: 7934 - Pages: 32
...Definition of Strategy Definition of Strategy: Strategy is a method or plan by which long term objectives will be achieved. Long term objectives are the specific result that an organization seeks to achieve in pursuing its basic mission. Business strategies may involve geographic expansion, diversification, acquisition, product development, market penetration, retrenchment, divestiture, liquidation and joint ventures. Strategies are potential actions that require top management decision and large amount of farm’s resources. Additionally strategies affect an organization’s long term prosperity, typically for at least five years, and thus are future oriented. Strategies have multifunctional and multidivisional consequences and required consideration of both the external and internal factors facing the firm. Most Strategic Management Model There are several Strategic Models are available and used in different organizations but following are the most used strategic models: 1. PEST analysis 2. STEER Analysis 3. Five Forces Model 4. Strategic Group Map 5. SWOT analysis 6. Blue Ocean Strategies 7. Open innovation 8. McKinsey seven S model Company Detailed Profile including mission & vision and Organogram Company Detail Profile Square pharmaceutical is now the most leading company in Bangladesh since 1985 and is now on its way to becoming a high performance global player. Today it has achieved a state of mind among consumers...
Words: 5122 - Pages: 21
...the liberalization of 1991 enabled the industry to become what it is today. Many of the Indian companies principally observe reverse engineering of the new processes for manufacturing drugs at low costs. Although some of the companies have taken baby steps towards innovating newer drugs, the industry as a whole tends to follow this business model. The lack of patent protection, on the other hand, makes India undesirable for multinational companies that have dominated the market. So the pharmaceutical market in India has a tremendous potential for indigenousness. In this context, comparing a global pharmaceutical company with its Indian counterpart becomes evident. GlaxoSmithKline and Ranbaxy: A Comparison GlaxoSmithKline is a British multinational pharmaceutical company also dealing in biologics, vaccines and consumer healthcare. Headquartered at London, it is the world’s sixth largest pharmaceutical company. The company was established in 2000 by the merger of Glaxo Wellcome and SmithKline Beckman Corporation. A giant with around 99,000 employees, GlaxoSmithKline recorded a revenue of 25.6 billion pounds in 2013. Net income was recorded 5.2 billion pounds, while operating income stood at 7.7 billion pounds. Ranbaxy Laboratories Limited is an Indian multinational pharmaceutical company incorporated in India in 1961. It is headquartered at Gurgaon, India. The company went public in 1973 and Japanese...
Words: 3952 - Pages: 16
...Contents 1.0 Executive Summary 3 1.1 The Products 4 1.3 Mission Statement 5 1.4 Management Team 5 1.5 Sales Forecasts 6 1.6 Expansion Plan 7 2.0 Company and Financing Summary 8 2.1 Registered Name and Corporate Structure 8 2.2 Financial Position 8 2.3 Investment 10 2.4 Management Equity 10 3.0 Products and Services 11 3.1 Online Sales of Products. 11 Baby Care 11 Grocery 11 Personal Care 11 OTC Medicines 11 Cosmetic 12 Fitness Centre 12 3.4 Shipping and Handling Fees 12 4.0 Strategic and Market Analysis 13 4.1 Economic Outlook 13 4.3 Customer Profile 13 4.4 Competition 14 5.0 Marketing Plan 17 5.1 Marketing Objectives 17 5.2 Marketing Strategies 17 5.3 Pricing 18 The Company believes in healthy Competition, so we will offer our Products at competitive Price. The Company will offer discounts on the large order or at wholesale Quantity. 18 6.0 Organizational Plan and Personnel Summary 18 6.1 Corporate Organization 18 6.2 Organizational Budget 19 6.3 Management NOTE: 20 7.0 Financial Plan 23 7.1 Underlying Assumptions 23 7.2 Sensitivity Analysis 23 7.3 Source of Funds 24 7.4 General Assumptions 24 Monthly Sales Revenue (PROJECTED) 25 Yearly Sales Forecast 26 7.5 Profit and Loss Statements 27 Executive Summary The Summit, RX Inc. (hereafter, “The Company”) business plan provides the structure and focus against which we can measure future financial positions for success in the near and far term. It serves...
Words: 7308 - Pages: 30
